Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rebecca Loret De Mola"'
Autor:
Sumedha Sudhaman, Eric Bouffet, Valerie Larouche, Deborah T. Blumenthal, Michael Osborn, Stefan S. Bielack, Ayse Bahar Ercan, Duncan Stearns, Cynthia Hawkins, Kim E. Nichols, Lauren Sambira, David Gass, Sandra Luna-Fineman, Charlotta Fröjd, Lindsey Hoffman, Lee Yi Yen, Gregory Thomas, Daniel C. Bowers, Rebecca Loret De Mola, Shlomi Constantini, Anne Bendel, Michael D. Taylor, David S. Ziegler, Tatiana Lipman, Uri Tabori, Scott Lindhorst, An Van Damme, Ted Laetsch, Jeffrey Knipstein, Brittany Campbell, Carol Durno, Gary Mason, Warren P. Mason, Elisabeth Koustenis, Magnus Sabel, David Samuel, Melyssa Aronson, Alyssa Reddy, Michal Oren, Sumita Roy, Patrick Tomboc, Vanan Magimairajan, Daniel Morgenstern, Ira Winer, Jacalyn Kelly, Cindy Zhang, Sara Carroll, Alvaro Lassaletta, Karen Gauvain, G. Rechavi, Stefanie Zimmermann, David Sumerauer, Melissa Edwards, Ailish Coblentz, Kristina A. Cole, Maura Massimino, Oz Mordechai, Nobuko Hijiya, Enrico Opocher, Trevor J. Pugh, Alexander Lossos, Ben George, Adam Shlien, Stefano Chiaravalli, Kami Wolfe Schneider, Margaret E. Wierman, Annika Bronsema, Jiil Chung, Gavin P. Dunn, Michal Zapotocky, M Remke, Santanu Sen, Rina Dvir, Peter B. Dirks
Pediatric brain tumors with replication repair deficiency (RRD) are hypermutant and may respond favorably to immune checkpoint inhibition (ICI). We are collecting ongoing clinical and molecular data from patients with RRD hypermutant cancers treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860de980ca1d4267f20f2495d6848858
https://europepmc.org/articles/PMC6477295/
https://europepmc.org/articles/PMC6477295/
Autor:
Duncan Stearns, Rina Dvir, Daniel Morgenstern, Jacalyn Kelly, Ailish Coblentz, Peter B. Dirks, Adam Shlien, Michael Osborn, Nobuko Hijiya, An Van Damme, Gregory Thomas, Anne Bendel, Elisabeth Koustenis, Gavin P. Dunn, Charlotta Fröjd, Sumedha Sudhaman, Lee Yi Yen, Michael D. Taylor, Stefanie Zimmermann, Alexander Lossos, David S. Ziegler, Melyssa Aronson, G. Rechavi, Lauren Sambira, Kami Wolfe Schneider, David Gass, Ben George, Ted Laetsch, Alyssa Reddy, Michal Zapotocky, Eric Bouffet, Cynthia Hawkins, Alberto Broniscer, Scott Lindhorst, Sumita Roy, Patrick Tomboc, Vanan Magimairajan, Maura Massimino, Margaret E. Wierman, Tatiana Lipman, Mark Remke, Karen Gauvain, David Sumerauer, Uri Tabori, Ira Winer, Magnus Sabel, Cindy Zhang, Sara Carroll, Shlomi Constantini, Stefan Bielack, Ayse Bahar Ercan, Valerie Larouche, Stefano Chiaravalli, Lindsey Hoffman, Daniel C. Bowers, Alvaro Lassaletta, Jeffrey Knipstein, Enrico Opocher, Kristina A. Cole, Annika Bronsema, Rebecca Loret De Mola, Jiil Chung, Santanu Sen, Oz Mordechai, Carol Durno, Warren P. Mason, David Samuel, Trevor J. Pugh, Michal Oren, Melissa Edwards, Deborah T. Blumenthal, Sandra Luna-Fineman, Gary Mason
Publikováno v:
Neuro-Oncology
Pediatric brain tumors with replication repair deficiency (RRD) are hypermutant and may respond to immune checkpoint inhibition (ICI). We performed a consortium registry study of ICI in recurrent RRD cancers. Clinical and companion biomarkers were co